|
Healthcare professional reported injecting a patient in the lips, oral commissures, perioral, and rhytids with 1 syringe syringes of juvéderm® volbella¿ xc.Two months later, the patient had a dental cleaning and experienced ¿3 non-inflammatory nodules/bumps¿ later that month in the upper lip that were found via an early manual palpation.The same day as the palpation exam, the patient was on zyrtec and had pepcid added.Two and a half weeks later, the patient was treated with ibuprofen 400 mg tid po and hyaluronidase with additional hyaluronidase given 3 days later.Two weeks later, the patient the patient was examined again, where the number of nodules was found to have increased (7 in the upper lip and 6 in the lower lip), and the patient was treated with doxycycline and a medrol dosepak that were started 3 days later.Event was ongoing.
|
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|